TuHURA Biosciences, Inc.
HURA
$2.16
-$0.43-16.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.30M | 3.62M | 2.70M | 8.51M | 6.22M |
| Total Receivables | 167.70K | 667.70K | 419.70K | 3.61M | 515.20K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 149.00K | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 367.50K | 333.50K | 386.80K | 414.80K | 7.59M |
| Total Current Assets | 6.98M | 4.62M | 3.50M | 12.54M | 14.33M |
|
|
|||||
| Total Current Assets | 6.98M | 4.62M | 3.50M | 12.54M | 14.33M |
| Net Property, Plant & Equipment | 675.60K | 685.20K | 378.00K | 266.70K | 313.30K |
| Long-term Investments | 10.74M | 10.74M | 13.55M | 13.55M | -- |
| Goodwill | 10.74M | 10.74M | 13.55M | 13.55M | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.31M | 11.31M | 8.26M | 8.26M | -- |
| Total Assets | 29.70M | 27.35M | 25.70M | 34.62M | 14.64M |
|
|
|||||
| Total Accounts Payable | 3.95M | 3.77M | 4.13M | 3.65M | 3.08M |
| Total Accrued Expenses | 1.91M | 1.75M | 1.31M | 3.23M | 1.53M |
| Short-term Debt | -- | 197.40K | 493.40K | 434.00K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 206.90K | 199.00K | 128.10K | 125.00K | 164.60K |
| Total Finance Division Other Current Liabilities | -- | -- | 2.78M | 7.73M | -- |
| Total Other Current Liabilities | -- | -- | 2.78M | 7.73M | -- |
| Total Current Liabilities | 6.07M | 5.92M | 8.83M | 15.17M | 4.78M |
|
|
|||||
| Total Current Liabilities | 6.07M | 5.92M | 8.83M | 15.17M | 4.78M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 197.40K | 493.40K | 434.00K | -- |
| Capital Leases | 250.10K | 303.60K | 85.00K | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 197.90K | 197.90K | -- | -- | -- |
| Total Liabilities | 6.51M | 6.42M | 8.92M | 15.17M | 4.78M |
|
|
|||||
| Common Stock & APIC | 171.63M | 161.84M | 150.92M | 146.49M | 130.43M |
| Retained Earnings | -148.72M | -141.18M | -134.42M | -127.32M | -117.79M |
| Treasury Stock & Other | -- | -- | -- | -- | -3.06M |
| Total Common Equity | 22.91M | 20.65M | 16.50M | 19.17M | 9.58M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 278.50K | 278.50K | 278.50K | 278.50K | 278.50K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 278.50K | 278.50K | 278.50K | 278.50K | 278.50K |
|
|
|||||
| Total Common Equity | 22.91M | 20.65M | 16.50M | 19.17M | 9.58M |
| Total Preferred Equity | 278.50K | 278.50K | 278.50K | 278.50K | 278.50K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 23.19M | 20.93M | 16.78M | 19.45M | 9.86M |
|
|
|||||